THU-162-The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets

Autor: Merat, Shahin, Sharifi, Amir-Houshang, Shayesteh, Ali Akbar, Minakari, Mohammad, Fattahi, Mohammad Reza, Moini, Maryam, Roozbeh, Fatemeh, Mansour-Ghanaei, Fariborz, Afshar, Behrooz, Mokhtare, Marjan, Amiriani, Taghi, Sofian, Masomeh, Somi, Mohammad-Hossein, Agah, Shahram, Maleki, Iradj, Latifnia, Maryam, Hormati, Ahmad, Khoshnia, Masoud, Sohrabi, Masoud, Malekzadeh, Reza
Zdroj: In Journal of Hepatology April 2019 70(1) Supplement:e233-e233
Databáze: ScienceDirect
Externí odkaz: